Switching to Retatrutide | What to Expect & When

Retatrutide is an upcoming weight loss treatment that has generated significant interest. While it is not yet widely available, many people are already considering whether switching from current treatments like Mounjaro or Wegovy could be an option in the future.

Important Note

Retatrutide is still in clinical trials and is not currently approved for routine use. The information below is based on current knowledge and may change as more data becomes available.

What You’ll Learn

What Retatrutide is and how it differs
Why people may consider switching
How switching might work in the future
What to expect when it becomes available

Why Consider Switching to Retatrutide?

Interest in Retatrutide comes from early clinical trial results suggesting strong weight loss outcomes.

Potential for significant weight loss
Different mechanism targeting three hormone pathways
Future treatment option for those not satisfied with current results

See Retatrutide Results for more detail.

How Is It Different from Mounjaro and Wegovy?

Wegovy: GLP-1 based treatment
Mounjaro: Dual-action (GLP-1 + GIP)
Retatrutide: Triple-action (GLP-1 + GIP + glucagon)

This difference is why it is considered a next-generation option.

How Might Switching Work?

Although official guidance is not yet available, switching will likely follow a similar pattern to current treatments:

Stopping your current medication
Starting Retatrutide at an appropriate dose
Gradual dose increases

See Switching Between Treatments for how switching works today.

Will You Need to Start at a Low Dose?

It is likely that switching to Retatrutide will involve starting at a lower dose, even if you are already on another treatment.

This helps your body adjust safely.

What to Expect When Switching

Your appetite may change during the transition
You may experience adjustment symptoms
Results may take time to stabilise

This is similar to switching between existing treatments.

When Will Retatrutide Be Available?

Retatrutide is currently in late-stage clinical trials. Availability will depend on regulatory approval and rollout in the UK.

Is It Worth Waiting for Retatrutide?

While Retatrutide shows promise, current treatments like Mounjaro and Wegovy are already available and effective.

For many people, starting treatment now may be more beneficial than waiting.

Not Sure What to Do?

Compare current options: Mounjaro vs Wegovy
See available results: Mounjaro Results
Understand expectations: How Much Weight Can You Lose?